多发性骨髓瘤是多发性骨髓瘤的一种
1Mary C. Vrtis, PhD, MSN, RN, OCN, NEA-BC, FCN, is the Chief Executive Clinical Education, Nurses' Hands Across the Globe, Front Royal, Virginia.
Home healthcare now
|May 6, 2024
概括
多发性髓瘤 (MM) 是一种带有严重并发症和治疗的骨髓癌. 针对不良反应,复发和跌倒的早期干预对于最佳的患者结果至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 癌症研究 癌症研究
背景情况:
- 多发性骨髓瘤 (MM) 是骨髓中的血细胞癌,在2023年美国的发病率和死亡率显著.
- MM并发症包括贫血,衰竭,骨损失和病理性骨折.
- 虽然有有效的MM治疗方法,但它们具有严重的副作用和复发风险,特别是某些遗传变异.
研究的目的:
- 突出综合性患者管理在多发性骨髓瘤的关键需要.
- 强调早期干预对不良影响和疾病复发的重要性.
- 强调对MM患者提供支持性护理服务的必要性.
主要方法:
- 这项研究是对当前多发性骨髓瘤治疗挑战和患者护理需求的审查.
- 它综合了有关疾病并发症,治疗副作用和患者支持的信息.
主要成果:
- 毫毫米患者面临复杂的多种药物治疗方案,需要仔细的管理和监测.
- 副作用,疾病进展和病理性骨折需要警的医疗和护理护理.
- 综合性支持性护理,包括家庭护理和物理/职业治疗,至关重要.
结论:
- 多发性骨髓瘤的有效管理需要患者和瘤团队之间的积极沟通.
- 通过专门的干预来解决治疗副作用,疾病并发症和跌倒风险,可以改善患者的治疗结果.
- 家庭护理护理和康复服务对于管理MM患者的安全,坚持和生活质量至关重要.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
01:31Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
01:27Disorders of Leukocytes
938
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
938